NLS Pharmaceutics
Quick facts
Phase 3 pipeline
- NLS-2 · Neurology
NLS-2 is a selective orexin-2 receptor agonist that promotes wakefulness by enhancing neural signaling in brain regions responsible for arousal and alertness.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: